Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Philippe J Zamor"'
Autor:
Maribel Rodriguez-Torres, Eric Läwitz, Bienvenido Yangco, Lennox Jeffers, Steven-Huy Han, Paul J. Thuluvath, Vinod Rustgi, Stephen Harrison, Reem Ghalib, John M. Vierling, Velimir Luketic, Philippe J. Zamor, Natarajan Ravendhran, Timothy R. Morgan, Brian Pearlman, Christopher O’Brien, Hicham Khallafi, Nikolaos Pyrsopoulos, George Kong, Fiona McPhee, Philip D. Yin, Eric Hughes, Michelle Treitel
Publikováno v:
Annals of Hepatology, Vol 15, Iss 6, Pp 834-845 (2016)
Background. Patient race and ethnicity have historically impacted HCV treatment response. This phase 3 study evaluated daclatasvir with peginterferon-alfa-2a/ribavirin (pegIFN alfa-2a/RBV) in treatment-naive black/African American (AA), Latino, and w
Externí odkaz:
https://doaj.org/article/758320977acf45fe990b1d476981cdbb
Autor:
Ashley M. Lane, Philippe J. Zamor
Publikováno v:
Clinics in Liver Disease. 25:689-709
Hepatitis B was discovered by researchers who were investigating jaundice associated with blood transfusions as well as parenterally administered medications. Through trial and error, the HBV was identified. There are specific tests that detect HBV i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b49d2ee39aa5a77742aacbf6aa26c11
https://doi.org/10.1016/j.cld.2021.06.012
https://doi.org/10.1016/j.cld.2021.06.012
Autor:
Georgios Papatheodoridis, Jordan J. Feld, Massimo Colombo, Juergen K. Rockstroh, David Mutimer, Yiran Hu, Ashley Brown, Christophe Moreno, John F. Dillon, Reem Ghalib, Douglas E. Dylla, Eric Lawitz, Anne F Luetkemeyer, David R. Nelson, Eric Crown, Ira M. Jacobson, Philippe J. Zamor, Richard Skoien, Sandra S. Lovell
Publikováno v:
The American Journal of Gastroenterology
INTRODUCTION: Pangenotypic, all-oral direct-acting antivirals, such as glecaprevir/pibrentasvir (G/P), are recommended for treatment of hepatitis C virus (HCV) infection. Concerns exist about the impact on efficacy in patients with suboptimal adheren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d09546b54ec35e40995afabb0db929
https://doi.org/10.14309/ajg.0000000000001332
https://doi.org/10.14309/ajg.0000000000001332
Autor:
Thomas, Ludden, Lindsay, Shade, Jeremy, Thomas, Mark W, Russo, Michael, Leonard, Philippe J, Zamor, Charity G, Patterson, Hazel, Tapp
Publikováno v:
Journal of the American Board of Family Medicine : JABFM. 35(5)
Increased screening efforts and the development of effective antiviral treatments have led to marked improvement in Hepatitis C (HCV) patient outcomes. However, many people in the US are believed to have undiagnosed HCV. Successful screening strategi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5f76a7398660bf1dfd7eedc3dd0e2bc6
https://pubmed.ncbi.nlm.nih.gov/36257701
https://pubmed.ncbi.nlm.nih.gov/36257701
Publikováno v:
American Journal of Gastroenterology. 117:e892-e892
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fa2f92c0999838aa58638a82a4f0364
https://doi.org/10.14309/01.ajg.0000861568.51233.c9
https://doi.org/10.14309/01.ajg.0000861568.51233.c9
Autor:
Michael Robertson, John M Vierling, Velimir Luketic, George J Hanna, Luis A. Balart, Peggy Hwang, Reem Ghalib, Brian Pearlman, Bach-Yen Nguyen, Rohit Talwani, Natarajan Ravendhran, Philippe J Zamor, Eliav Barr
Publikováno v:
American Journal of Gastroenterology. 113:863-871
Although direct-acting antiviral regimens have dramatically improved the treatment of hepatitis C virus (HCV) infection, there is some evidence that black race may be an independent predictor of treatment failure. We report a retrospective analysis o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc4aeaa38803cef0872814e11cbfc9d
https://doi.org/10.1038/s41395-018-0053-4
https://doi.org/10.1038/s41395-018-0053-4
Publikováno v:
Infectious Disease Clinics of North America. 32:347-370
Injection drug use is the most common transmission route for hepatitis C. High rates of infection are observed among individuals on opioid agonist therapy. Although people who inject drugs carry the highest burden, few have initiated treatment. We pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf5b63f482d60970d6ce1a79e85022ff
https://doi.org/10.1016/j.idc.2018.02.001
https://doi.org/10.1016/j.idc.2018.02.001
Autor:
Mark Russo, Philippe J. Zamor
Publikováno v:
Clinical Liver Disease. 10:75-78
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::103adf774ef77c072db08802eed1aa48
https://doi.org/10.1002/cld.659
https://doi.org/10.1002/cld.659
Publikováno v:
Journal of Gastrointestinal Oncology. 8:229-242
Chronic hepatitis B virus (HBV) and chronic hepatitis C virus (HCV) are associated with hepatic fibrosis and development of hepatocellular carcinoma (HCC). There are differences and variation with the incidence of HCC worldwide. Additionally, HCC dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a2ad71a2cc55ea708714b9afe52810e
https://doi.org/10.21037/jgo.2017.03.14
https://doi.org/10.21037/jgo.2017.03.14
Autor:
Thomas Ludden, Charity G. Patterson, Michael Leonard, Sveta Mohanan, Philippe J. Zamor, Jeremy Thomas, Hazel Tapp, Mark W. Russo, Brisa Urquieta de Hernandez, Lindsay Shade
Publikováno v:
Journal of the American Board of Family Medicine : JABFM. 33(3)
Background: Increased screening efforts and the development of effective antiviral treatments have led to marked improvement in hepatitis C (HCV) patient outcomes. However, many people in the United States are still believed to have undiagnosed HCV.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5655cc686c75a6a8d97f34c36401d999
https://pubmed.ncbi.nlm.nih.gov/32430372
https://pubmed.ncbi.nlm.nih.gov/32430372